Eugeen Vanmechelen

country of citizenship: Belgium

occupation: researcher

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 114

Date

Title

Authors

2020-02-13

The β-Secretase BACE1 in Alzheimer's Disease

Harald Hampel, Eugeen Vanmechelen, Ann De Vos, Lynn D. Kramer, Robert Nistico
2020-10-16

β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification

Andrea Vergallo, Filippo Sean Giorgi, Riqiang Yan, Eugeen Vanmechelen, Filippo Caraci, Harald Hampel
2019-12-23

Association of brain network dynamics with plasma biomarkers in subjective memory complainers

Eugeen Vanmechelen, Kaj Blennow, Henrik Zetterberg, Enrica Cavedo, Andrea Vergallo, Marie-Claude Potier, Harald Hampel, INSIGHT-preAD study group, Alzheimer Precision Medicine Initiative (APMI)
2019-10-01

Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD

Eugeen Vanmechelen, Andrea Vergallo, Harald Hampel, Alzheimer Precision Medicine Initiative (APMI), Marie-Odile Habert
2019-12-12

Critical Steps to be Taken into Consideration Before Quantification of β-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical Environment

Eugeen Vanmechelen
2019-05-18

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease

Eugeen Vanmechelen, Ann De Vos, Kaj Blennow, Henrik Zetterberg, Enrica Cavedo, Andrea Vergallo, Marie-Claude Potier, Harald Hampel, INSIGHT-preAD study group, Christian Neri, Alzheimer Precision Medicine Initiative (APMI), Marie-Odile Habert
2019-07-23

Pre-analytical stability of novel cerebrospinal fluid biomarkers

Eline Willemse, Yannick Vermeiren, Vera Mendes, Eugeen Vanmechelen
2019-03-01

The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?

Youssra K Al-Hilaly, Caroline Smet, Joke Verelst, Eugeen Vanmechelen, Bernard J Hanseeuw, Miguel Medina, Luc Buée, Isabelle Landrieu
2018

Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease

Dag Aarsland, Knut Waterloo, Kaja Nordengen, Eugeen Vanmechelen, Geir Bråthen, Tormod Fladby
2018-02-17

Digital ELISA for the quantification of attomolar concentrations of Alzheimer's disease biomarker protein Tau in biological samples.

Elena Pérez Ruiz, Karen Ven, Karen Leirs, Ann De Vos, Eugeen Vanmechelen
2018-03-09

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.

Sebastiaan Engelborghs, Wiesje van der Flier, Philip Scheltens, Henrik Zetterberg, Kaj Blennow, Charlotte Teunissen, Anne M Fagan, Eugeen Vanmechelen, Maria Bjerke, Ulf Andreasson, Eline Willemse, Jack H Ladenson
2018-05-28

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale

Constance Delaby, Sophie Navucet, Eugeen Vanmechelen, Audrey GABELLE, Hugo Vanderstichele
2017-07-03

Multicenter Analytical Validation of Aβ40 Immunoassays

Bea Kuiperij, Marcel Verbeek, Eugeen Vanmechelen
2017-08-30

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke

Eugeen Vanmechelen, Sebastiaan Engelborghs, Henrik Zetterberg, Kaj Blennow, Maria Bjerke
2016-04-26

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid

Michael G Schlossmacher, Brit Mollenhauer, Eugeen Vanmechelen, Hugo Vanderstichele, Walter J Schulz-Schaeffer
2016-07-06

The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease

Christine Van Broeckhoven, Sebastiaan Engelborghs, Eugeen Vanmechelen, Caroline Robberecht, Ellen De Roeck, Charles Duyckaerts
2016-01-07

Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases.

Marcel Verbeek, Eugeen Vanmechelen, Sebastiaan Engelborghs, Philip Scheltens, Hans-Joachim Knölker, Charlotte Teunissen, Linda J C van Waalwijk van Doorn, Bea Kuiperij, Marleen J A Koel-Simmelink, Jens Wiltfang, Harry Twaalfhoven
2016-07-01

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

Josef Pannee, Eugeen Vanmechelen, Maria Bjerke, Kaj Blennow, Henrik Zetterberg, Hugo Vanderstichele, Erik Stoops, Manu Vandijck, Piotr Lewczuk, Vesna Kostanjevecki, Robert M Umek, Andreas Jeromin, Ingrid Zegers
2015-08-19

A Practical Guide to Immunoassay Method Validation

Eugeen Vanmechelen, Sebastiaan Engelborghs, Şermin Genç, Marcel Verbeek, Barbara Mroczko, Henrik Zetterberg, Kaj Blennow, Bengt Winblad, Charlotte Teunissen, Brit Mollenhauer, Ulf Andreasson, Lucilla Parnetti, Tormod Fladby, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, Davide Chiasserini, Niels Kruse, Bea Kuiperij, Marleen J A Koel-Simmelink, Luka Kulic, Piotr Lewczuk
2015-04-01

TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies

Eugeen Vanmechelen, Christine Van Broeckhoven, Julie van der Zee, Sebastiaan Engelborghs, John Q. Trojanowski, Joery Goossens
2015-08-28

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

Eugeen Vanmechelen, Sanna-Kaisa Herukka, Brit Mollenhauer, Anja H. Simonsen, Lucilla Parnetti
2015-05-15

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

Giovanni B. Frisoni, Eugeen Vanmechelen, Luisella Bocchio Chiavetto, Sebastiaan Engelborghs, Niels Kruse, Erden Eren, Madalena Martins, María-Salud García-Ayllón, Şermin Genç, Daniel A. Alcolea, Marcel Verbeek, Flavio Nobili, Henrik Zetterberg, Kaj Blennow, Brit Mollenhauer, Magda N. Tsolaki, Lucilla Parnetti, Tormod Fladby, Branislav Kováčech, Catarina R. Oliveira, Alberto Lleó, Davide Chiasserini, Bea Kuiperij, Javier Sáez, Staffan Persson, Justyna M C Bahl, Inês Baldeiras, Olymbia Gkatzima, Norbert Zilka
2015-06-16

C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.

Eugeen Vanmechelen, Sebastiaan Engelborghs, Christine Van Broeckhoven, Henrik Zetterberg, Kaj Blennow, Erik Portelius, Ulf Andreasson, Caroline Robberecht, Kristel Sleegers
2014-12-24

Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics

Eugeen Vanmechelen, Sebastiaan Engelborghs, Juan Lopez, Isabelle Huvent, Morvane Colin, Valerie Buée-Scherrer, Marie-Christine Galas, Guy Lippens, Luc Buée, Joris Winderickx
2014-01-15

Increased CSF α-synuclein levels in Alzheimer's disease: correlation with tau levels.

Eugeen Vanmechelen, Sebastiaan Engelborghs, Manu Vandijck, Peter Paul De Deyn, Jean-Jacques Martin, Sylvie Slaets, Nathalie Le Bastard
2014-07

TDP-43 AS A BIOMARKER FOR FRONTOTEMPORAL LOBE DEGENERATION: A SYSTEMATIC REVIEW OF EXISTING ANTIBODIES

Julie van der Zee, Eugeen Vanmechelen, Joery Goossens
2014-03

Tau as a molecular biomarker in cerebrospinal fluid and plasma

Henrik Zetterberg, Kaj Blennow, Eugeen Vanmechelen, Erik Portelius
2013-07

Detection and quantification of novel tau/phospho-tau epitopes in CSF using a multiplex assay approach

Henrik Zetterberg, Kaj Blennow, Eugeen Vanmechelen
2013-01-01

Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia

Eugeen Vanmechelen, Sebastiaan Engelborghs, Hugo Vanderstichele, Els Coart, Jean-Jacques Martin, Nathalie Le Bastard
2013-01-01

Functional mannose-binding lectin haplotype variants are associated with Alzheimer's disease.

Eugeen Vanmechelen, Kaj Blennow, Lennart Minthon, Staffan Nilsson, Annica Sjölander
2013-10-04

Monitoring of β-amyloid dynamics after human traumatic brain injury.

Niklas Marklund, Eugeen Vanmechelen, Lars Hillered, Henrik Zetterberg, Kaj Blennow
2013-07

A new era of CSF biomarker testing in the field of Alzheimer's disease

Eugeen Vanmechelen, Erik Stoops

Human - wd:Q30533725

Welcome to Inventaire

the library of your friends and communities

learn more